10-Q 1 hnoi10q043024.htm FORM 10-Q
false 2024 Q2 --10-31 0001342916 0001342916 2023-11-01 2024-04-30 0001342916 2024-06-27 0001342916 2024-04-30 0001342916 2023-10-31 0001342916 us-gaap:SeriesAPreferredStockMember 2024-04-30 0001342916 us-gaap:SeriesAPreferredStockMember 2023-10-31 0001342916 2024-02-01 2024-04-30 0001342916 2023-02-01 2023-04-30 0001342916 2022-11-01 2023-04-30 0001342916 hnoi:PreferredStockSeriesAMember 2023-10-31 0001342916 us-gaap:CommonStockMember 2023-10-31 0001342916 hnoi:StockPayableMember 2023-10-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2023-10-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2023-10-31 0001342916 us-gaap:RetainedEarningsMember 2023-10-31 0001342916 hnoi:PreferredStockSeriesAMember 2024-01-31 0001342916 us-gaap:CommonStockMember 2024-01-31 0001342916 hnoi:StockPayableMember 2024-01-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2024-01-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2024-01-31 0001342916 us-gaap:RetainedEarningsMember 2024-01-31 0001342916 2024-01-31 0001342916 hnoi:PreferredStockSeriesAMember 2022-10-31 0001342916 us-gaap:CommonStockMember 2022-10-31 0001342916 hnoi:StockPayableMember 2022-10-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2022-10-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001342916 us-gaap:RetainedEarningsMember 2022-10-31 0001342916 2022-10-31 0001342916 hnoi:PreferredStockSeriesAMember 2023-01-31 0001342916 us-gaap:CommonStockMember 2023-01-31 0001342916 hnoi:StockPayableMember 2023-01-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2023-01-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2023-01-31 0001342916 us-gaap:RetainedEarningsMember 2023-01-31 0001342916 2023-01-31 0001342916 hnoi:PreferredStockSeriesAMember 2023-11-01 2024-01-31 0001342916 us-gaap:CommonStockMember 2023-11-01 2024-01-31 0001342916 hnoi:StockPayableMember 2023-11-01 2024-01-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2023-11-01 2024-01-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2023-11-01 2024-01-31 0001342916 us-gaap:RetainedEarningsMember 2023-11-01 2024-01-31 0001342916 2023-11-01 2024-01-31 0001342916 hnoi:PreferredStockSeriesAMember 2024-02-01 2024-04-30 0001342916 us-gaap:CommonStockMember 2024-02-01 2024-04-30 0001342916 hnoi:StockPayableMember 2024-02-01 2024-04-30 0001342916 hnoi:ShareSubscriptionReceivableMember 2024-02-01 2024-04-30 0001342916 us-gaap:AdditionalPaidInCapitalMember 2024-02-01 2024-04-30 0001342916 us-gaap:RetainedEarningsMember 2024-02-01 2024-04-30 0001342916 hnoi:PreferredStockSeriesAMember 2022-11-01 2023-01-31 0001342916 us-gaap:CommonStockMember 2022-11-01 2023-01-31 0001342916 hnoi:StockPayableMember 2022-11-01 2023-01-31 0001342916 hnoi:ShareSubscriptionReceivableMember 2022-11-01 2023-01-31 0001342916 us-gaap:AdditionalPaidInCapitalMember 2022-11-01 2023-01-31 0001342916 us-gaap:RetainedEarningsMember 2022-11-01 2023-01-31 0001342916 2022-11-01 2023-01-31 0001342916 hnoi:PreferredStockSeriesAMember 2023-02-01 2023-04-30 0001342916 us-gaap:CommonStockMember 2023-02-01 2023-04-30 0001342916 hnoi:StockPayableMember 2023-02-01 2023-04-30 0001342916 hnoi:ShareSubscriptionReceivableMember 2023-02-01 2023-04-30 0001342916 us-gaap:AdditionalPaidInCapitalMember 2023-02-01 2023-04-30 0001342916 us-gaap:RetainedEarningsMember 2023-02-01 2023-04-30 0001342916 hnoi:PreferredStockSeriesAMember 2024-04-30 0001342916 us-gaap:CommonStockMember 2024-04-30 0001342916 hnoi:StockPayableMember 2024-04-30 0001342916 hnoi:ShareSubscriptionReceivableMember 2024-04-30 0001342916 us-gaap:AdditionalPaidInCapitalMember 2024-04-30 0001342916 us-gaap:RetainedEarningsMember 2024-04-30 0001342916 hnoi:PreferredStockSeriesAMember 2023-04-30 0001342916 us-gaap:CommonStockMember 2023-04-30 0001342916 hnoi:StockPayableMember 2023-04-30 0001342916 hnoi:ShareSubscriptionReceivableMember 2023-04-30 0001342916 us-gaap:AdditionalPaidInCapitalMember 2023-04-30 0001342916 us-gaap:RetainedEarningsMember 2023-04-30 0001342916 2023-04-30 0001342916 hnoi:SmallEquipmentMember 2024-04-30 0001342916 hnoi:LargeEquipmentMember 2024-04-30 0001342916 us-gaap:VehiclesMember 2024-04-30 0001342916 us-gaap:VehiclesMember 2023-10-31 0001342916 hnoi:SmallEquipmentMember 2023-10-31 0001342916 hnoi:LargeEquipmentMember 2023-10-31 0001342916 us-gaap:SeriesAPreferredStockMember hnoi:MrOwensMember hnoi:PatentPurchaseAgreementMember 2023-01-23 2023-01-24 0001342916 hnoi:LeaseForSuiteBMember 2023-11-13 2023-11-14 0001342916 hnoi:LeaseForSuiteCMember 2024-01-03 2024-01-04 0001342916 srt:DirectorMember 2023-01-04 0001342916 srt:MinimumMember 2023-01-06 0001342916 srt:MaximumMember 2023-01-06 0001342916 us-gaap:CommonStockMember 2023-01-06 0001342916 us-gaap:PreferredStockMember 2023-01-06 0001342916 hnoi:StockSubscriptionAgreementsMember srt:BoardOfDirectorsChairmanMember 2022-11-01 2023-01-31 0001342916 hnoi:StockSubscriptionAgreementsMember srt:DirectorMember 2023-01-16 2023-01-17 0001342916 hnoi:StockSubscriptionAgreementsMember srt:DirectorMember 2023-01-10 2023-01-11 0001342916 srt:DirectorMember 2023-01-02 0001342916 hnoi:StockSubscriptionAgreementsMember srt:BoardOfDirectorsChairmanMember 2023-01-30 2023-01-31 0001342916 hnoi:StockSubscriptionAgreementsMember srt:DirectorMember 2023-06-08 2023-06-09 0001342916 2023-05-01 2023-07-31 0001342916 2023-07-31 0001342916 2023-08-01 2023-10-31 0001342916 us-gaap:CommonStockMember 2023-10-09 0001342916 hnoi:VivarisCapitalLLCMember hnoi:StockReceivableMember 2022-03-30 2022-03-31 0001342916 us-gaap:SubsequentEventMember hnoi:VivarisCapitalLLCMember 2024-05-01 2024-05-03 0001342916 hnoi:StockReceivableMember 2023-11-01 2024-04-30 0001342916 hnoi:StockPayableMember 2023-11-01 2024-04-30 0001342916 us-gaap:SeriesAPreferredStockMember hnoi:CustodianVenturesLLCMember 2019-10-14 0001342916 srt:ChiefExecutiveOfficerMember 2019-10-13 2019-10-14 0001342916 us-gaap:SeriesAPreferredStockMember 2019-10-13 2019-10-14 0001342916 us-gaap:SeriesAPreferredStockMember srt:ChiefExecutiveOfficerMember 2022-08-15 2022-08-16 0001342916 hnoi:MrOwensMember us-gaap:SeriesAPreferredStockMember hnoi:PatentPurchaseAgreementMember 2023-01-23 2023-01-24 0001342916 hnoi:HNOGreenFuelsMember 2021-11-30 2021-12-01 0001342916 hnoi:HNOGreenFuelsMember 2022-11-01 2023-10-31 0001342916 hnoi:HNOGreenFuelsMember 2024-04-30 0001342916 hnoi:HNOGreenFuels1Member 2022-05-30 2022-05-31 0001342916 hnoi:HNOGreenFuels1Member 2024-04-30 0001342916 hnoi:HNOGreenFuels2Member 2022-09-28 2022-09-29 0001342916 hnoi:HNOGreenFuels2Member 2024-04-30 0001342916 hnoi:HNOGreenFuels3Member 2022-10-19 2022-10-20 0001342916 hnoi:HNOGreenFuels3Member 2024-04-30 0001342916 hnoi:HNOGreenFuels4Member 2023-02-28 2023-03-01 0001342916 hnoi:HNOGreenFuels4Member 2024-04-30 0001342916 hnoi:HNOGreenFuels5Member 2023-03-07 2023-03-08 0001342916 hnoi:HNOGreenFuels5Member 2024-04-30 0001342916 hnoi:HNOGreenFuels6Member 2023-03-22 2023-03-23 0001342916 hnoi:HNOGreenFuels6Member 2024-04-30 0001342916 hnoi:HNOGreenFuels7Member 2023-04-02 2023-04-03 0001342916 hnoi:HNOGreenFuels7Member 2024-04-30 0001342916 hnoi:HNOGreenFuels8Member 2023-04-12 2023-04-13 0001342916 hnoi:HNOGreenFuels8Member 2024-04-30 0001342916 hnoi:HNOGreenFuels9Member 2023-04-16 2023-04-17 0001342916 hnoi:HNOGreenFuels9Member 2024-04-30 0001342916 hnoi:HNOGreenFuelsMember 2023-11-01 2024-04-30 0001342916 2024-01-30 2024-01-31 0001342916 2023-10-30 2023-10-31 0001342916 2022-10-30 2022-10-31 0001342916 hnoi:SimpleAgreementForFutureEquityMember 2023-07-10 0001342916 hnoi:PurchaseAndSaleAgreementMember hnoi:TCFElrodLLCMember 2023-08-27 2023-08-28 0001342916 hnoi:PurchaseAndSaleAgreementMember hnoi:TCFElrodLLCMember 2023-12-04 0001342916 us-gaap:CommonStockMember 2024-05-01 2024-05-02 0001342916 hnoi:StockPayablesMember 2024-05-01 2024-05-02 0001342916 us-gaap:SubsequentEventMember us-gaap:CommonStockMember hnoi:StockSubscriptionAgreementsWithAccreditedInvestorsMember 2024-05-01 2024-05-02 0001342916 us-gaap:CommonStockMember us-gaap:SubsequentEventMember hnoi:StockSubscriptionAgreementsWithAccreditedInvestorsMember 2024-05-02 0001342916 us-gaap:CommonStockMember hnoi:VivarisCapitalLLCMember 2022-03-29 2022-03-31 0001342916 us-gaap:SubsequentEventMember hnoi:VivarisCapitalLLCMember 2024-05-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended April 30, 2024

 

OR

 

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to __________

 

Commission File Number: 000-56568

 

HNO INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-2781289
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

41558 Eastman Drive

Suite B

Murrieta, California 

(Address of principal executive offices)

 

 

92562

(Zip Code)

     

(951) 305-8872

(Registrant's telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

 

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 1 
 

 

Large accelerated filer               ¨ Accelerated filer                          ¨
Non-accelerated filer            x Smaller reporting company     x
Emerging growth company            ¨    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. As of June 27, 2024, the registrant had 410,719,655 outstanding shares of Common Stock.

 

 

 

 

 2 
 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

This report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties. You should not place undue reliance on these forward-looking statements. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons, including the risks described in our Form 10-K filed on January 29, 2024, and other filings we make with the Securities and Exchange Commission. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made. We do not intend to update any of the forward-looking statements after the date of this report to conform these statements to actual results or to changes in our expectations, except as required by law.

 

The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with our audited financial statements and related notes thereto included elsewhere in this report, and in our Annual Report on Form 10-K filed on January 29, 2024.

 

 

 

 

 

 

 

 3 
 

 

HNO INTERNATIONAL, INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED APRIL 30, 2024

 

TABLE OF CONTENTS

 

    PAGE
PART I FINANCIAL INFORMATION  
Item 1. Financial Statements (Unaudited) 5
  Unaudited Condensed Balance Sheets as of April 30, 2024 and October 31, 2023 5
  Unaudited Condensed Statements of Operations for the Three and Six Months Ended April 30, 2024 and 2023 6
  Unaudited Condensed Statement of Stockholders’ Deficit for the Three and Six Months Ended April 30, 2024 and for the Year Ended October 31, 2023 7
  Unaudited Condensed Statements of Cash Flows for the Six Months Ended April 30, 2024 and 2023 8
  Notes to Unaudited Condensed Financial Statements 9
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 19
Item 3. Quantitative and Qualitative Disclosures About Market Risk 23
Item 4. Controls and Procedures 23
PART II OTHER INFORMATION  
Item 1A. Risk Factors 24
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 25
Item 5. Other Information 26
Item 6. Exhibits 27
  Signatures 28

 

 

 

 

 4 
 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

                 
HNO INTERNATIONAL, INC.
CONDENSED BALANCE SHEETS
(Unaudited)
         
      April 30,       October 31,  
      2024       2023  
ASSETS                
Current Assets                
Cash   $ 77,459     $ 235,159  
Accrued interest receivable     5,185           
Due from related party              56,392  
Total Current Assets     82,644       291,551  
                 
Non-Current Assets                
Property and equipment, net     943,055       767,938  
Intangible assets, net     77,273       79,324  
Long term asset     136,725       103,821  
ROU asset     149,662           
Security deposits              100,000  
Total Non-Current Assets     1,306,715       1,051,083  
TOTAL ASSETS   $ 1,389,359     $ 1,342,634  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT                
LIABILITIES                
Current Liabilities                
Accounts payable     16,738       925  
Accrued interest payable     54,982       41,270  
Lease liability     55,051           
Payroll tax     2,838       17,640  
Advances, related party     710,585           
   Notes payable, related party     785,000       785,000  
Total Current Liabilities     1,625,194       844,835  
                 
Non-Current Liability                
Lease liability     95,033           
Long term notes payable, related party     590,000       590,000  
Total Non-Current Liability     685,033       590,000  
Total Liabilities     2,310,227       1,434,835  
                 
STOCKHOLDERS’ DEFICIT                
Preferred stock, par value $0.001 per share; 15,000,000 shares authorized            
Series A, par value $0.001 per share; 10,000,000 shares authorized; 10,000,000 and 10,000,000 shares issued and outstanding as of April 30, 2024 and October 31, 2023, respectively     10,000       10,000  
Common stock, par value $0.001 per share; 985,000,000 shares authorized; 419,553,485 and 419,341,584 shares issued and outstanding as of April 30, 2024 and October 31, 2023, respectively     419,553       419,341  
Common stock payable     79,500       32,251  
Common stock subscription receivable     (23,750 )     (23,750 )
Additional paid-in capital     41,291,591       41,079,902  
Accumulated deficit     (42,697,762 )     (41,609,945 )
Total Stockholders’ Deficit     (920,868 )     (92,201 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 1,389,359     $ 1,342,634  
                 
The accompanying notes are an integral part of these unaudited condensed financial statements. 

 

 5 
 

 

                 
HNO INTERNATIONAL, INC.
CONDENSED STATEMENT OF OPERATIONS
(Unaudited)
                 
    For the Three Months Ended
April 30,
  For the Six Months Ended
April 30,
    2024   2023   2024   2023
                 
Revenue   $        $        $        $ 13,000  
Cost of goods sold                                (5,885 )
Gross Profit                                7,115  
                                 
Operating expenses                                
Advertising and marketing                                3,000  
General and administrative expenses     526,635       288,055       1,009,505       489,610  
Depreciation and amortization     36,809       3,463       70,092       4,346  
                                 
Total Operating Expenses     563,444       291,518       1,079,597       496,956  
Other Income (Expenses)                                
Interest income     5,192       1       5,492       4  
Interest expense     (6,781 )     (6,331 )     (13,712 )     (12,384 )
Total Other (Expenses)     (1,589 )     (6,330 )     (8,220 )     (12,380 )
Loss from Operations   $ (565,033 )   $ (297,848 )   $ (1,087,817 )   $ (502,221 )
Net Loss   $ (565,033 )   $ (297,848 )   $ (1,087,817 )   $ (502,221 )
PER SHARE AMOUNTS                                
Basic and diluted net loss
per share
    (0.00 )     (0.00 )     (0.00 )     (0.00 )
Weighted average number of common shares outstanding - basic and diluted     419,491,234       408,166,703       419,439,854       286,817,647  
                                 
The accompanying notes are an integral part of these unaudited condensed financial statements.

 

  

 

 

 6 
 

 

                                                                         
HNO INTERNATIONAL, INC.
CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT
For the three months and six months ended April 30, 2024 and 2023
(Unaudited)
    Series A Preferred Stock   Common Stock   Stock   Share Subscription   Additional Paid-in   Accumulated   Total Stockholders'
    Shares   Amount   Shares   Amount   Payable   Receivable   Capital   Deficit   Deficit
                                     
Balance at October 31, 2023     10,000,000     $ 10,000       419,341,584     $ 419,341     $ 32,251     $ (23,750 )   $ 41,079,902     $ (41,609,945 )   $ (92,201 )
Regulation A stock issuances     —                  91,501       92       33,999                91,409                125,500  
Net loss for the three months ended January 31, 2024     —                  —                                             (522,784 )     (522,784 )
Balance at January 31, 2024     10,000,000     $ 10,000       419,433,085     $ 419,433     $ 66,250     $ (23,750 )   $ 41,171,311     $ (42,132,729 )   $ (489,485 )
Regulation A stock issuances     —                  120,400       120       13,250                120,280                133,650  
Net loss for the three months ended April 30, 2024     —                  —                                             (565,033 )     (565,033 )
Balance at April 30, 2024     10,000,000     $ 10,000       419,553,485     $ 419,553     $ 79,500     $ (23,750 )   $ 41,291,591     $ (42,697,762 )   $ (920,868 )
                                                                         
Balance at October 31, 2022     5,000,000     $ 5,000       105,265,299     $ 105,265     $        $ (10,000 )   $ 38,957,921     $ (40,168,610 )   $ (1,110,424 )
Common stock issued for cash     —                  182,000,000       182,000                                           182,000  
Common stock based compensation     —                  2,025,000       2,025                                           2,025  
Common stock issued for settlement of debt     —                  20,000,000       20,000                                           20,000  
Common stock to be issued from cash proceeds     —                  —                  100,000                                  100,000  
Series A preferred issued pursuant to patent agreement     5,000,000       5,000       —                                    77,500                82,500  
Net loss for the three months ended January 31, 2023     —                  —                                             (204,373 )     (204,373 )
Balance at January 31, 2023     10,000,000     $ 10,000       309,290,299     $ 309,290     $ 100,000     $ (10,000 )   $ 39,035,421     $ (40,372,983 )   $ (928,272 )
Common stock issued for cash     —                  100,000,000       100,000       (100,000 )                                    
Net loss for the three months ended April 30, 2023     —                  —                                             (297,848 )     (297,848 )
Balance at April 30, 2023     10,000,000     $ 10,000       409,290,299     $ 409,290     $        $ (10,000 )   $ 39,035,421     $ (40,670,831 )   $ (1,226,120 )
                                                                         
The accompanying notes are an integral part of these unaudited condensed financial statements.

  

 7 
 

 

         
HNO INTERNATIONAL, INC.
CONDENSED STATEMENT OF CASH FLOWS
(Unaudited)
         
    For the Six Months Ended
April 30,
    2024   2023
         
Cash Flow from Operating Activities                
Net loss for the period   $ (1,087,817 )   $ (502,221 )
                 
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization     70,092       4,346  
ROU asset     (149,662 )         
Lease liability     95,033           
Shares issued for services              2,025  
Changes in operating assets and liabilities:                
Decrease in due from related party     56,392           
Increase in accrued interest receivable     (5,185 )         
Increase in accounts payable     15,813           
Increase in accrued interest payable     13,712       12,383  
Increase in lease liability     55,051          
Decrease in payroll taxes     (14,802 )         
Net Cash Used in Operating Activities     (951,373 )     (483,467 )
                 
Cash Flows from Financing Activities                
Proceeds from related party advances     710,585       230,000  
Proceeds from security deposits     100,000       6,800  
Proceeds from sale of common stock subscription payable     47,249           
Proceeds from sale of common stock     211,901       384,500  
Net Cash Provided by Financing Activities     1,069,735       621,300  
                 
Cash Flows from Investing Activities                
Purchase of property and equipment     (186,777 )     (129,294 )
Purchase of long term asset     (89,285 )     (46,430 )
Net Cash Used in Investing Activities     (276,062 )     (175,724 )
                 
Net increase in cash     (157,700 )     (37,891 )
Cash at beginning of period     235,159       51,109  
Cash at end of period   $ 77,459     $ 13,218  
                 
Supplemental Disclosure of Interest and Income Taxes Paid:                
Interest paid during the period   $        $     
Income taxes paid during the period   $        $     
                 
Supplemental Disclosure for Non-Cash Investing and Financing Activities:                
Series A preferred stock issued pursuant to patent agreement   $        $ 82,500  
Common stock issued for conversion of debt   $        $ 20,000  
The accompanying notes are an integral part of these unaudited condensed financial statements.
 8 
 

HNO INTERNATIONAL, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

APRIL 30, 2024

(Unaudited)

 

 

NOTE 1 – ORGANIZATION AND BASIS OF ACCOUNTING

 

Organization

 

HNO International, Inc. (the “Company”) was incorporated in the State of Nevada on May 2, 2005 under the name American Bonanza Resources Limited. On August 4, 2009, the Company acquired Clenergen Corporation Limited (UK), a United Kingdom corporation (“Limited”), and succeeded to the business of Limited. Limited acquired the assets of Rootchange Limited, a biofuel and biomass research and development company, in April 2009. On March 19, 2009, the Company changes its name to Clenergen Corporation. On July 8, 2020, the Company changed its name to Excoin Ltd. and on August 31, 2021, the Company changed its name to HNO International, Inc. its current name.

 

The Company specializes in the design, integration, and development of green hydrogen-based clean energy technologies. With the Company’s management having over 13 years of experience in the field of green hydrogen production, the Company is committed to providing scalable products that help businesses and communities decarbonize, reduce emissions, and cut operational costs. HNO stands for Hydrogen and Oxygen. The Company is at the forefront of developing innovative solutions, such as the Compact Hydrogen Refueling System (CHRS) and the Compact Hydrogen Production System (CHPS), which can be used to produce green hydrogen for various applications including fuel cell electric vehicles, hydrogen internal combustion engines, heating, and cooking. The CHPS is highly scalable, capable of producing 100-2,000 (or more) kilograms of hydrogen per day for commercial use in various applications. In addition, the Company develops energy systems that complement the zero-emissions EV infrastructure, reduce harmful emissions, and cut maintenance costs of commercial diesel fleets. By integrating components from leading industry partners, the Company aims to transition fossil fuels to cleaner alternatives and promote lower emissions.

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”), and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments, consisting of normal recurring adjustments, which management believes are necessary to fairly present the financial position, results of operations and cash flows of the Company for the six months ended April 30, 2024.

 

Use of Estimates

 

The preparation of the condensed financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amount of revenues and expenses during the reporting period. The management makes its best estimate of the outcome for these items based on information available when the condensed financial statements are prepared.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.

 

Employee Stock-Based Compensation

 

The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.

 

 9 
 

Income Taxes

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized.

 

Revenue Recognition

 

We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASC 606 includes provisions within a five-step model that includes identifying the contract with a customer, identifying the performance obligations in the contract, determining the transaction price, allocating the transaction price to the performance obligations, and recognizing revenue when, or as, an entity satisfies a performance obligation.

 

During the six months ended April 30, 2024 and 2023, the Company had revenue of $0 and $13,000. Revenue was recognized from hydrogen engineering services and combustion solutions.

 

Basic and Diluted Net Loss per Common Share

Basic loss per common share is computed by dividing the net loss by the weighted average number of shares of common stock outstanding for each period. Diluted loss per share is computed by dividing the net loss by the weighted average.

Number of shares of common stock outstanding plus the dilutive effect of shares issuable through the common stock equivalents. The weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.

Property and Equipment

 

Property and equipment are carried at cost and, less accumulated depreciation. The cost of repairs and maintenance is expensed as incurred; major replacements and improvements are capitalized. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposal. The Company examines the possibility of decreases in the value of property and equipment when events or changes in circumstances reflect the fact that their recorded value may not be recoverable.

 

The Company’s property and equipment mainly consists of computer and laser equipment. Depreciation is computed using the straight-line method over the estimated useful lives of the assets.

 

   
   Useful life
Small equipment  3 Years
Large equipment  7 Years
Vehicles  4 Years

 

Intangible Assets

 

Intangible assets consist of patents acquired in an asset purchase agreement (see Note 5). The estimated useful life of these assets was determined to be 20 years. The Company periodically evaluates the reasonableness of the useful lives of these assets. Once these assets are fully amortized, they are removed from the accounts. These assets are reviewed for impairment or obsolescence when events or changes in circumstances indicate that the carrying amount may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash flows or other valuation techniques. The Company has no intangibles with indefinite lives.

 

Impairment of Long-Lived Assets

 

The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. To determine recoverability of a long-lived asset, management evaluates whether the estimated future undiscounted net cash flows from the asset are less than its carrying amount. If impairment is indicated, the long-lived asset would be written down to fair value. Fair value is determined by an evaluation of available price information at which assets could be bought or sold, including quoted market prices, if available, or the present value of the estimated future cash flows based on reasonable and supportable assumptions.

 

 10 
 

Leases

 

The Company accounts for leases in accordance with ASC 842, Leases (“ASC 842”). At contract inception, the Company determines if an arrangement is or contains a lease. Where the Company is the lessee, for each lease with a term greater than twelve months, the Company records a right-of-use asset and lease liability. A right-of-use asset represents the economic benefit conveyed to the Company by the right to use the underlying asset over the lease term. A lease liability represents the obligation to make lease payments arising from the use of the asset over the lease term. As most of the Company’s leases do not provide an implicit interest rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease. Leases with an initial expected term of 12 months or less are not recorded in the Balance Sheet and the related lease expense is recognized on a straight-line basis over the lease term.

Adoption of Recent Accounting Pronouncements

 

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

Reclassification of Prior Year Presentation

 

Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the reported results of operations.

 

NOTE 3 – GOING CONCERN

 

At April 30, 2024, we had an accumulated deficit of $42,697,762. We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. We will be required to raise additional funds through public or private financing, additional collaborative relationships, or other arrangements until we are able to raise revenues to a point of positive cash flow. We are evaluating various options to further reduce our cash requirements to operate at a reduced rate, as well as options to raise additional funds, including obtaining loans and selling common stock. There is no guarantee that we will be able to generate enough revenue and/or raise capital to support operations.

 

Based on the above factors, substantial doubt exists about our ability to continue as a going concern for one year from the issuance of these condensed financial statements.

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

Property and equipment consisted of the following:

 

      
  

April 30,

2024

 

October 31,

2023

Vehicles  $60,702   $60,702 
Small equipment  $32,943   $8,879 
Large equipment   954,391    735,297 
Property and Equipment, Gross  $1,048,036   $804,878 
    Less: Accumulated depreciation   (104,981)   (36,940)
Property and Equipment, Net  $943,055   $767,938 

 

Depreciation expenses for the six months ended April 30, 2024, and 2023 was $68,041 and $3,250, respectively.

 

 

 11 
 

NOTE 5 – INTANGIBLE ASSETS

 

Patents Acquired Under Patent Purchase Agreement

On January 24, 2023, the Company entered into a Patent Purchase Agreement with Donald Owens, the Company's Chairman of the Board of Directors, to acquire several patents related to hydrogen supplemental systems for on-demand hydrogen generation for internal combustion engines and a method and apparatus for increasing combustion efficiency and reducing particulate matter emissions in jet engines. In exchange for these patents, the Company issued 5,000,000 shares of its Series A Preferred Stock to Mr. Owens, valued at $82,500.

 

The details of the patents acquired are listed in the table below, which includes information on the patent numbers, titles, and status in various countries.

 

 

 

COUNTRY APPLN NO

PATENT

NUMBER

TITLE STATUS

 

 

US

 

 

13/844,267

 

 

8,757,107

HYDROGEN SUPPLEMENTAL SYSTEM FOR ON-DEMAND HYDROGEN GENERATION FOR INTERNAL COMBUSTION ENGINES

 

 

Issued

 

 

US

 

 

13/922,351

 

 

9,453,457

HYDROGEN SUPPLEMENTAL SYSTEM FOR ON-DEMAND HYDROGEN GENERATION FOR INTERNAL COMBUSTION ENGINES

 

 

Issued

 

 

US

 

 

14/016,388

 

 

9,476,357

METHOD AND APPARATUS FOR INCREASING COMBUSTION EFFICIENCY AND REDUCING PARTICULATE MATTER EMISSIONS IN JET ENGINES

 

 

Issued

 

 

US

 

 

14/326,801

 

 

9,267,468

HYDROGEN SUPPLEMENTAL SYSTEM FOR ON-DEMAND HYDROGEN GENERATION FOR INTERNAL COMBUSTION ENGINES

 

 

Issued

 

 

US

 

 

17/047,041

 

 

10,920,717

HYDROGEN PRODUCING SYSTEM AND DEVICE FOR IMPROVING FUEL EFFICIENCY AND REDUCING EMISSIONS OF INTERNAL COMBUSTION AND/OR DIESEL ENGINES

 

 

Issued

 

 

AUSTRALIA

 

 

2019405749

 

 

2019405749

HYDROGEN PRODUCING SYSTEM AND DEVICE FOR IMPROVING FUEL EFFICIENCY AND REDUCING EMISSIONS OF INTERNAL COMBUSTION AND/OR DIESEL ENGINES

 

 

Issued

 

CHINA

201980092511.1   HYDROGEN PRODUCING SYSTEM AND DEVICE FOR IMPROVING FUEL EFFICIENCY

 

Pending

 

EUROPE

 

19900413.6.

  HYDROGEN PRODUCING SYSTEM AND DEVICE FOR IMPROVING FUEL EFFICIENCY

 

Pending

 

JAPAN

 

2021-535288

  HYDROGEN PRODUCING SYSTEM AND DEVICE FOR IMPROVING FUEL EFFICIENCY

 

Pending 

 

Intangible assets at April 30, 2024 and October 31, 2023, consisted of the following:

 

           
    Useful
Life (years)
  April 30, 2024  

October 31,

2023

Patents     20     $ 82,500     $ 82,500  
Less: Accumulated amortization             (5,227 )     (3,176
   Intangible assets, net           $ 77,273     $ 79,324  

 

Amortization expense for the six months ended April 30, 2024, and 2023 was $2,051 and $1,096, respectively.

  

 

 12 
 

NOTE 6 – LEASES

 

Operating leases

 

The Company has an operating lease agreement for office space in Murrieta, California, expiring on November 30, 2026.

 

On December 3, 2020, the Company entered into an operating lease with the landlord, Demarius Holdings, Inc., ending November 30, 2023, for the office spaces located at 41558 Eastman Drive, Suites B and C, Murrieta, California 92562. Both suites are approximately 2,088 square feet of space. The Company’s principal executive office is located at 41558 Eastman Drive, Suite B, Murrieta, California 92562. Suite C is utilized for testing and research equipment.

 

On November 14, 2023, the lease for Suite B was extended for 36 months to November 30, 2026. The monthly rental amount for Suite B is $2,501 for the period from December 1, 2023, to November 30, 2024, with an increase to $2,573.00 for the period from December 1, 2024, to November 30, 2025, and an increase to $2,647.00 for the period from December 1, 2025, to November 30, 2026.

 

On January 4, 2024, the lease for Suite C was extended for 34 months to November 30, 2026. The monthly rental amount for Suite C is $2,434.00 for the period from February 1, 2024, to November 30, 2024, with an increase to $2,506.00 for the period from December 1, 2024, to November 30, 2025, and an increase to $2,555.00 for the period from December 1, 2025, to November 30, 2026.

 

The Company has active operating lease arrangements for office space. The Company is typically required to make fixed minimum rent payments relating to its right to use the underlying leased assets. The Company was required to classify such leases as operating leases in accordance with the provisions of ASC 842 - Leases. Therefore, the Company recognized operating lease liabilities with corresponding Right-Of-Use ("ROU") assets based on the present value of the minimum rental payments of such leases. 

 

As most of the Company’s leases do not provide an implicit interest rate, the lease liability is calculated at lease commencement as the present value of unpaid lease payments using the Company’s estimated incremental borrowing rate. The incremental borrowing rate represents the rate of interest that the Company would have to pay to borrow an amount equal to the lease payments on a collateralized basis over a similar term and is determined using a portfolio approach based on information available at the commencement date of the lease.As of April 30, 2024, the ROU asset was $149,662 and operating lease liabilities were $150,084. The operating lease liabilities consist of a current portion of $55,051 and a non-current portion of $95,033. The weighted average remaining lease term was 2.6 years and the weighted average discount rate was 4.14%.

Remaining lease term as of April 30, 2024:

 

         
Year   Operating Lease Payment
2024     $ 30,455  
2025     $ 60,909  
2026 and above     $ 65,986  
Total Payments     $ 157,350  

 

NOTE 7 – COMMON STOCK

 

The Company is authorized to issue 985,000,000 shares of common stock, par value $0.001.

 

Increase in Authorized Capital Stock

On January 4, 2023, the Board of Directors and a majority of the Company’s stockholders approved the proposal to increase the number of shares of capital stock that the Company is authorized to issue to 1,000,000,000. On January 6, 2023, the Company filed a Certificate of Amendment to the Articles of Incorporation with the Secretary of State of Nevada to increase the total authorized capital from 510,000,000 shares to 1,000,000,000 shares consisting of 985,000,000 shares of common stock, par value $0.001, and 15,000,000 shares of preferred stock, par value $0.001.

 13 
 

Stock Issued

 

During the quarter ended January 31, 2023, the Company entered into Stock Subscription Agreements with Donald Owens, the Company’s Chairman of the Board of Directors, whereby the Company privately sold a total of 175,000,000 shares of its common stock for a cash purchase price of $175,000. Donald Owens was an “accredited investor” (under Rule 506 (b) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”)). The $175,000 in proceeds from the sale of common stock will be used for operating capital. The shares were ‘restricted securities’ under Rule 144 of the Securities Act. 

 

On January 17, 2023, the Company entered into a Stock Subscription Agreement with William Parker, a member of the Company’s Board of Directors, whereby the Company privately sold a total of 5,000,000 shares of its common stock for a cash purchase price of $5,000. William Parker was an “accredited investor” (under Rule 506 (b) of Regulation D under the Securities Act). The $5,000 in proceeds from the sale of common stock will be used for operating capital. The shares were ‘restricted securities’ under Rule 144 of the Securities Act. 

 

On January 11, 2023, the Company entered into a Stock Subscription Agreement with Hossein Haririnia, the Company’s Treasurer and a member of the Board of Directors, whereby the Company privately sold a total of 2,000,000 shares of its common stock for a cash purchase price of $2,000. Hossein Haririnia was an “accredited investor” (under Rule 506 (b) of Regulation D under the Securities Act). The $2,000 in proceeds from the sale of common stock will be used for operating capital. The shares were ‘restricted securities’ under Rule 144 of the Securities Act. 

 

The Company's Board of Directors granted approval for the issuance of 2,025,000 shares of our common stock with a value of $0.001 on January 2, 2023, in exchange for services rendered to the Company. These shares were considered "restricted securities" under Rule 144 and were issued under the exemption provided by Section 4(a)(2) of the Securities Act.

 

On January 31, 2023, the Company entered into Stock Subscription Agreements with Donald Owens, the Company’s Chairman of the Board of Directors, whereby the Company privately sold a total of 100,000,000 shares of its common stock for a cash purchase price of $100,000. Donald Owens was an “accredited investor” (under Rule 506 (b) of Regulation D under the Securities Act). The $100,000 in proceeds from the sale of common stock will be used for operating capital. The shares were ‘restricted securities’ under Rule 144 of the Securities Act.  As of January 31, 2023, these shares had not yet been issued and therefore were recorded as stock payable. On February 1, 2023, these shares were issued.

 

On June 9, 2023, the Company entered into a Stock Subscription Agreement with Hossein Haririnia, the Company’s Treasurer and a member of the Board of Directors, whereby the Company privately sold a total of 8,000,000 shares of its common stock for a cash purchase price of $8,000. Hossein Haririnia was an “accredited investor” (under Rule 506 (b) of Regulation D under the Securities Act). The $8,000 in proceeds from the sale of common stock will be used for operating capital. The shares were issued as ‘restricted securities’ under Rule 144 of the Securities Act. 

 

During the quarter ended July 31, 2023, the Company issued 1,968,032 shares of common stock at a fixed price of $1.00 per share for a total of $1,968,032 in cash under the Company’s Regulation A offering, which was qualified by the SEC on May 3, 2023.

 

During the quarter ended October 31, 2023, the Company issued 58,500 shares of common stock at a fixed price of $1.00 per share for a total of $58,500 in cash under the Company’s Regulation A offering, which was qualified by the SEC on May 3, 2023.

 

On October 9, 2023, the Company issued 24,753 shares of common stock valued at $20,000 as a commitment fee for equity financing. The shares were issued in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act, and Rule 506(b) of Regulation D under the Securities Act, based, in part, on the representations of the investor.

 

During the quarter ended January 31, 2024, the Company issued 91,501 shares of common stock at a fixed price of $1.00 per share for a total of $91,501 in cash under the Company’s Regulation A offering, which was qualified by the SEC on May 3, 2023.

 

During the quarter ended April 30, 2024, the Company issued 120,400 shares of common stock at a fixed price of $1.00 per share for a total of $120,400 in cash under the Company’s Regulation A offering, which was qualified by the SEC on May 3, 2023.

 

As of April 30, 2024 and October 31, 2023, the Company had 419,553,485 and 419,341,584 shares of common stock issued and outstanding, respectively.

 

 14 
 

Stock Receivable

 

On March 31, 2022, the Company issued 10,000,000 shares of common stock to Vivaris Capital, LLC, in connection with an Advisory Agreement. However, Vivaris Capital, LLC never paid for the shares, and a dispute arose. The dispute centered around the respective performance under the Advisory Agreement.

 

As per the Settlement Agreement executed on May 3, 2024 (see Note 12), the 10,000,000 shares were canceled, and the Company paid Vivaris Capital, LLC a settlement amount of $15,500, resolving the dispute and nullifying any outstanding receivables related to the stock issuance.

 

As of April 30, 2024, the Company issued 13,750 shares of common stock under Regulation A offering to various shareholders that have not yet paid for shares; therefore, $13,750 has been classified as common stock receivable.

 

Stock Payable

 

As of April 30, 2024, the Company sold 79,500 shares of common stock under its Regulation A offering to various shareholders that have not yet been issued by the transfer agent; therefore, $79,500 has been classified as common stock payable.

 

NOTE 8 – PREFERRED STOCK

 

The Company is authorized to issue 15,000,000 shares of preferred stock, par value $0.001.

 

Series A Preferred Stock

 

The Company is authorized to issue 10,000,000 shares of Series A preferred stock, par value $0.001. On October 14, 2019, the Company issued 10,000,000 shares of the Series A preferred stock to Custodian Ventures LLC, the Company controlled by David Lazar, the Company’s former Chief Executive Officer for forgiveness of related party debt totaling $10,000. Subsequently, in private transactions, the 10,000,000 shares of Series A Preferred were transferred. On August 16, 2022, Wilhelm Cashen, the Company’s former Chief Executive Officer, returned his 5,000,000 Series A preferred stock to the Company’s treasury.

 

On January 24, 2023, the Company issued 5,000,000 shares of its Series A Preferred Stock to Mr. Owens, valued at $82,500 for patents specified in Note 5.

 

As of April 30, 2024, and October 31, 2023, the Company had 10,000,000 and 10,000,000 shares of Series A preferred stock issued and outstanding, respectively.

 

NOTE 9 – RELATED PARTY TRANSACTIONS

 

Notes Payable, Related Party

 

On December 1, 2021, the Company issued a note payable in the amount of $500,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum. During the year ended October 31, 2023, $65,000 of principal was repaid. At April 30, 2024, there is $435,000 of principal and $23,132 of accrued interest due on this note. This note had a maturity date of January 1, 2023.

 

On May 31, 2022, the Company issued a note payable in the amount of $590,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of May 31, 2030. At April 30, 2024, there is $590,000 of principal and $22,630 of accrued interest due on this note.

 

On September 29, 2022, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and had a maturity date of October 31, 2023. At April 30, 2024, there is $50,000 of principal and $1,586 of accrued interest due on this note.

 

On October 20, 2022, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and had a maturity date of November 20, 2023. At April 30, 2024, there is $50,000 of principal and $1,529 of accrued interest due on this note.

 

On March 1, 2023, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of March 1, 2024. At April 30, 2024, there is $50,000 of principal and $1,167 of accrued interest due on this note.

 

 15 
 

On March 8, 2023, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of March 8, 2024. At April 30, 2024, there is $50,000 of principal and $1,148 of accrued interest due on this note.

 

On March 23, 2023, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of March 23, 2024. At April 30, 2024, there is $50,000 of principal and $1,107 of accrued interest due on this note.

 

On April 3, 2023, the Company issued a note payable in the amount of $50,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of April 3, 2024. At April 30, 2024, there is $50,000 of principal and $1,077 of accrued interest due on this note.

 

On April 13, 2023, the Company issued a note payable in the amount of $20,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of April 13, 2024. At April 30, 2024, there is $20,000 of principal and $420 of accrued interest due on this note.

 

On April 17, 2023, the Company issued a note payable in the amount of $30,000 to HNO Green Fuels, of which Donald Owens is Chief Executive Officer. This note bears an interest rate of 2% per annum and has a maturity date of April 17, 2024. At April 30, 2024, there is $30,000 of principal and $623 of accrued interest due on this note.

 

As of April 30, 2024, and October 31, 2023, these current and long-term notes payable had an outstanding balance of $1,375,000 and $1,375,000, respectively.

 

As of April 30, 2024 and October 31, 2023, the Company has recorded $54,419 and $41,270, respectively in accrued interest in connection with these notes in the accompanying condensed financial statements.

 

Extension of Promissory Notes

On January 17, 2024, the Company entered into an Extension to Promissory Note (the "1st Extension") with HNO Green Fuels, pursuant to the terms set forth in the 1st Extension. The 1st Extension amends the Promissory Note issued on December 1, 2021, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

On January 17, 2024, the Company entered into an Extension to Promissory Note (the "2nd Extension") with HNO Green Fuels, pursuant to the terms set forth in the 2nd Extension. The 2nd Extension amends the Promissory Note issued on September 29, 2022, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

On January 17, 2024, the Company entered into an Extension to Promissory Note (the "3rd Extension") with HNO Green Fuels, pursuant to the terms set forth in the 3rd Extension. The 3rd Extension amends the Promissory Note issued on October 20, 2022, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "4th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 4th Extension. The 4th Extension amends the Promissory Note issued on March 1, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "5th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 5th Extension. The 5th Extension amends the Promissory Note issued on March 8, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "6th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 6th Extension. The 6th Extension amends the Promissory Note issued on March 23, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "7th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 7th Extension. The 7th Extension amends the Promissory Note issued on April 3, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "8th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 8th Extension. The 8th Extension amends the Promissory Note issued on April 13, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 

On March 1, 2024, the Company entered into an Extension to Promissory Note (the "9th Extension") with HNO Green Fuels, pursuant to the terms set forth in the 9th Extension. The 9th Extension amends the Promissory Note issued on April 17, 2023, extending the Maturity Date to December 31, 2024. All prior defaults were waived by HNO Green Fuels.

 16 
 

 

Advances from Related Party

 

During the six months ended April 30, 2024, Donald Owens, the Company's Chairman of the Board of Directors, advanced $710,585 to the Company to cover operating expenses.

 

NOTE 10 – RECEIVABLE SETTLEMENT WITH RELATED PARTY

 

As of January 31, 2024, October 31, 2023 and October 31, 2022, the Company had a receivable from HNO Hydrogen Generators totaling $56,392 on its balance sheet, which was unsecured and due on demand. The receivable was fully settled through a transfer of assets in connection with a settlement agreement effective April 15, 2024. The settlement agreement involved the transfer of equipment, categorized into large and small equipment, with a combined value of $56,392. Specifically, large equipment was valued at $32,327, and small equipment at $24,065. This settlement agreement fully resolved all claims associated with the receivable. On the date of settlement, $5,185 was calculated as 5% interest and was recorded on the balance sheet as accrued interest receivable.

 

NOTE 11 – SIMPLE AGREEMENT FOR FUTURE EQUITY

 

On July 10, 2023, the Company entered into a Simple Agreement for Future Equity (the “SAFE”) with Varea, Inc. ("Varea"), a Delaware corporation. Pursuant to the SAFE, the Company is investing $500,000 (the "Purchase Amount") in Varea in exchange for the right to certain shares of Varea's Capital Stock. The agreement specifies that the Purchase Amount will be used for the Company's business operations over the next 12 months, subject to an agreed-upon budget.

 

Prior to entering into this SAFE, the Company had an existing financial arrangement with Varea LLC, whereby Varea LLC invoiced the Company for services rendered, which were recorded as expenses by HNOI. However, recognizing the potential for a more mutually beneficial arrangement, Varea Inc. proposed a revised approach. Under the newly proposed approach, Varea Inc. would submit a detailed budget outlining their anticipated monthly expenses, and HNO International, Inc. would view these expenses as an investment opportunity rather than mere costs. In exchange for funding Varea Inc.'s expenses, HNO International, Inc. would receive a post-money SAFE, which represents a future right to certain shares of Varea's Capital Stock. The transition from the previous invoicing system to the investment-based financial arrangement was agreed by both parties. The terms and conditions of the agreement, including the conversion of expenses into a potential future return on investment, were thoroughly assessed and discussed.

 

The balance of the SAFE on April 30, 2024 and October 31, 2023, was $136,725 and $103,821, respectively.

 

NOTE 12 – TERMINATION OF PROPERTY ACQUISITION AGREEMENT

 

On August 28, 2023, the Company entered into a Purchase and Sale Agreement (the “PSA”) with TCF Elrod, LLC. Pursuant to the PSA, the Company agreed to purchase property located in Harris County, Texas, including real property, improvements, development rights, and a lease. The purchase price for the property was $10,800,000. The Company paid a non-refundable earnest money deposit of $100,000, which was applied towards the purchase price of the sale proceeds as planned.

 

Specific conditions in the PSA were not met, the Company chose to exercise its right to terminate the PSA. Consequently, TCF Elrod, LLC refunded the $100,000 earnest money deposit to the Company on December 4, 2023.

 

NOTE 13 – SUBSEQUENT EVENTS

Common Stock Issued

 

Subsequent to the quarter ended April 30, 2024, the Company issued 156,278 shares of common stock under Regulation A for cash totaling $156,278.

 

Subsequent to the quarter ended April 30, 2024, the Company issued 62,750 shares of common stock under Regulation A for stock payables.

 

Subsequent to the quarter ended April 30, 2024, the Company entered into a Stock Subscription Agreement with accredited investors (under Rule 506 (b) of Regulation D under the Securities Act of 1933, as amended). Whereby the Company privately sold a total of 947,142 shares of its common stock, $0.001 par value per share, (“common stock”) for a cash purchase price of $260,500. The proceeds from the sale of common stock will be used for operating capital. The shares were issued as ‘restricted securities’ under Rule 144 of the Securities Act.

 

 17 
 

Settlement with Vivaris Capital, LLC

 

Subsequent to the quarter ended April 30, 2024, the Company entered into a Settlement Agreement and Mutual Release of All Claims with Vivaris Capital, LLC, resolving a dispute from a prior Advisory Agreement.

 

On March 31, 2022, the Company issued 10,000,000 shares of common stock to Vivaris Capital, LLC in connection with the Advisory Agreement. However, Vivaris Capital, LLC did not pay for these shares, resulting in a disagreement regarding performance under the agreement.

 

On May 3, 2024, the Company and Vivaris Capital, LLC executed a Settlement Agreement. As part of this agreement, the Company paid Vivaris Capital, LLC a settlement amount of $15,500, and the 10,000,000 shares issued to Vivaris Capital, LLC were canceled. This settlement nullifies any outstanding receivables related to the stock issuance and fully resolves the dispute between the parties.

 

As per the Settlement Agreement and Mutual Release of All Claims executed on May 3, 2024, the Company and Vivaris Capital, LLC have resolved their dispute. The settlement terms include the cancellation of the 10,000,000 shares issued to Vivaris Capital, LLC. Additionally, the Company agreed to pay Vivaris Capital, LLC a settlement amount of $15,500. This agreement nullifies any outstanding receivable related to the stock issuance and resolves the dispute in full.

 

 

 

 

 

 

 18 
 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Overview

 

HNO International, Inc. focuses on systems engineering design, integration, and product development to generate green hydrogen-based clean energy solutions to help businesses and communities decarbonize in the near term.

 

HNO stands for Hydrogen and Oxygen and our experienced management team has over 14 years of expertise in the green hydrogen production industry.

 

HNO International provides green hydrogen systems engineering design, integration, and products to multiple markets, which include: (i) the zero-emission vehicle and mobile equipment market consisting of hydrogen fuel cell electric passenger vehicles, material handling equipment such as forklifts and airport ground support equipment, as well as the medium and heavy-duty truck market; (ii) the current and emerging hydrogen gas markets encompassing ammonia, fertilizer, steel, mining, electronics, semiconductors, and fuel cell electric vehicles; (iii) and the gasoline and diesel engine emissions and maintenance reduction product and services market. 

 

On May 16, 2023, the Company began accepting subscription agreements from investors as part of an offering under Regulation A. This offering concluded automatically on May 5, 2024. During this period, the Company issued 2,457,461 shares of common stock under the Regulation A offering.

 

Results of Operations

 

For the three months ended April 30, 2024 and 2023

 

Revenue

 

For the three months ended April 30, 2024, we generated no revenue, consistent with no revenue for the three months ended April 30, 2023.

  

Operating Expenses

 

Operating expenses for the three months ended April 30, 2024, were $570,225 compared to $297,849 for the same period in 2023. This increase is attributable to the Company’s efforts to expand operations, which resulted in increased costs related to contract labor and general and administrative expenses. As 2024 progressed, we experienced a significant increase in hiring contract labor to support our Research and Development program. We also expanded our staff to support increased sales and marketing efforts.

 

Net Loss

 

Net loss for the three months ended April 30, 2024, was $565,033 compared to a net loss of $297,848 during the same period in 2023.

 

General and Administrative, and Contract Labor Expenses

 

General and Administrative, and Contract Labor expenses were $279,239 for the three months ended April 30, 2024, as compared to $196,935 during the same period in 2023. Operating expenses changed due to the Company’s efforts to expand operations, resulting in increased costs related to contract labor and general and administrative expenses.

 

For the six months ended April 30, 2024 and 2023

 

Revenue

 

For the six months ended April 30, 2024, we generated no revenue compared to $13,000 for the six months ended April 30, 2023. Revenue generated was from hydrogen engineering services and combustion solutions.

  

Operating Expenses

 

Operating expenses for the six months ended April 30, 2024, were $1,092,389 compared to $509,340 for the same period in 2023. This is attributable to the Company’s efforts to expand operations, which resulted in increased costs related to contract labor and general and administrative expenses. As 2043 progressed, we experienced a significant increase in hiring contract labor to support our Research and Development program. We also expanded our staff to support increased sales and marketing efforts.

 

 19 
 

Net Loss

 

Net loss for the six months ended April 30, 2023, was $1,087,817 compared to a net loss of $502,221 during the same period in 2023.

 

General and Administrative, and Contract Labor Expenses

 

General and Administrative, and Contract Labor expenses were $502,282 for the six months ended April 30, 2024, as compared to $301,387 during the same period in 2023. Operating expenses changed due to the Company’s efforts to expand operations, resulting in increased costs related to contract labor and general and administrative expenses.

 

Forward-Looking Considerations

 

The Company recognizes the possibility of future increases in labor or material costs. Factors such as evolving market conditions, potential inflation, and global economic dynamics are considered. We are actively monitoring these aspects to anticipate and navigate any forthcoming rises in labor or material expenses.

 

Cost-to-Revenue - The Company is assessing alterations in the relationship between cost of sales and revenue. We are examining the factors influencing these changes, including shifts in prices and fluctuations in the volume of services sold. Understanding the impact of these elements is crucial for maintaining a balanced and effective cost-to-revenue structure.

  

Liquidity and Capital Resources

 

We incurred a net loss for the three months ended April 30, 2024 and had an accumulated deficit of $42,697,762 at April 30, 2024. At April 30, 2024, we had a cash balance of $77,459, compared to a cash balance of $235,159 at October 31, 2023. At April 30, 2024, the working capital deficit was $1,637,583, compared to a working capital deficit of $553,284 at October 31, 2023. Our existing and available capital resources are not expected to be sufficient to satisfy our funding requirements through one year from the date of this filing in the absence of share issuances or other sources of financing.

 

We have not been able to generate sufficient cash from operating activities to fund our ongoing operations. We have raised capital through sales of common stock and debt securities.

 

The effect of existing or probable government regulations on our business is not known at this time. Due to the nature of our business, it is anticipated that there may be increasing government regulation that may cause us to have to take serious corrective actions or make changes to the business plan.

 

There are no external sources of liquidity available to the Company at this time. The Company will need to raise additional capital through equity financings or other means in order to continue operations and meet its obligations. Failure to obtain additional funding could have a material adverse effect on our financial condition and the results of operations.

 

Cash Flow

 

For the Six Months Ended April 30, 2024 and 2023

 

The following table summarizes our cash flows for the periods indicated below:

 

  

For the Six Months Ended April 30,

2024

 

For the Six Months Ended April 30,

2023

Cash Used in Operating Activities   (951,373)   (483,467)
Cash Provided by Financing Activities   1,069,735    621,300 
Net cash used in investing activities   (276,062)   (175,724)

 

 20 
 

Cash Used in Operating Activities

 

During the six months ended April 30, 2024, cash used in operating activities was $(951,373), primarily reflecting our net losses for the period, adjusted by non-cash charges such as depreciation and amortization, as well as changes in our working capital accounts. These changes mainly consisted of an increase in accrued interest payable, payroll taxes, and accounts payable, a decrease in the security deposit, and the settlement of a receivable from HNO Hydrogen Generators. The receivable, totaling $56,392, was fully settled through a transfer of equipment in connection with a settlement agreement effective April 15, 2024. The settlement agreement involved the transfer of large equipment valued at $32,327 and small equipment valued at $24,065.

During the six months ended April 30, 2023, cash used in operating activities was $(483,467), primarily reflecting our net losses for the period, adjusted by non-cash charges of share-based compensation, as well as changes in our working capital accounts. These changes mainly consisted of an increase in accrued interest payable, and a decrease in the security deposit.

 

Cash Provided by Financing Activities

During the six months ended April 30, 2024, cash provided by financing activities was $1,069,735, which consisted of proceeds from related party advances of $710,585, proceeds from the sale of common stock subscription payable of $47,249, and proceeds from the sale of common stock of $211,901.

During the six months ended April 30, 2023, cash provided by financing activities was $621,300, which consisted of proceeds from related party advances of $230,000 and proceeds from the sale of common stock of $384,500. 

 

Cash Provided by Investing Activities

During the six months ended April 30, 2024, cash used in investing activities was $(276,062), which consisted of the purchase of property and equipment and long-term assets.

During the six months ended April 30, 2023, cash used in investing activities was $(175,724), which consisted of the purchase of plant and equipment. 

 

Going Concern

 

The Company’s financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. During the six months ended April 30, 2024, the Company incurred a net loss of $1,087,817 and used cash in operating activities of $951,373, and on April 30, 2024, had stockholders’ deficit of $920,868. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and the classification of liabilities that might result from this uncertainty.

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements with any party.

 

Critical Accounting Policies

 

Our discussion and analysis of results of operations and financial condition are based upon our condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these condensed financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis, including those related to provisions for uncollectible accounts receivable, inventories, valuation of intangible assets and contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

STOCK-BASED COMPENSATION

 

The Company accounts for stock incentive awards issued to employees and non-employees in accordance with FASB ASC 718, Stock Compensation. Accordingly, stock-based compensation is measured at the grant date, based on the fair value of the award. Stock-based awards to employees are recognized as an expense over the requisite service period, or upon the occurrence of certain vesting events. Additionally, stock-based awards to non-employees are expensed over the period in which the related services are rendered.

 21 
 

DERIVATIVE LIABILITY

 

In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Paragraph 815-15-25-1 the conversion feature and certain other features are considered embedded derivative instruments, such as a conversion reset provision, a penalty provision and redemption option, which are to be recorded at their fair value as its fair value can be separated from the convertible note and its conversion is independent of the underlying note value. The Company records the resulting discount on debt related to the conversion features at initial transaction and amortizes the discount using the effective interest rate method over the life of the debt instruments. The conversion liability is then marked to market each reporting period with the resulting gains or losses shown in the statements of operations.

 

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. 

 

The Company follows ASC Section 815-40-15 (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent exercise and settlement provisions.

 

The Company evaluates its convertible debt, options, warrants or other contracts, if any, to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with paragraph 810-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability. In the event that the fair value is recorded as a liability, the change in fair value is recorded in the statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value at the date of conversion, exercise or cancellation and then that the related fair value is reclassified to equity. 

 

The Company utilizes the binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The binomial option pricing model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the remaining contractual term of the instrument granted.

 

REVENUE RECOGNITION

 

In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which we expect to be entitled to receive in exchange for these goods or services. The provisions of ASC 606 include a five-step process by which we determine revenue recognition, depicting the transfer of goods or services to customers in amounts reflecting the payment to which we expect to be entitled in exchange for those goods or services. ASC 606 requires us to apply the following steps: (1) identify the contract with the customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when, or as, we satisfy the performance obligation. We recognize revenue for the sale of our products upon delivery to a customer.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40). This update amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity's own equity and improves and amends the related EPS guidance for both Subtopics. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2023, which means it will be effective for our fiscal year beginning October 31, 2024. Early adoption is permitted but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. We are currently evaluating the impact of ASU 2020-06 on our financial statements.

 

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company's present or future financial statements.

 

 

 22 
 

PROPOSED TRANSACTIONS

 

The Company is not anticipating any transactions.

 

CHANGES IN ACCOUNTING POLICIES INCLUDING INITIAL ADOPTION

 

There were no recent accounting pronouncements that have or will have a material effect on the Company’s financial position or results of operations.

 

FINANCIAL INSTRUMENTS

 

The main risks of the Company’s financial instruments are exposed to are credit risk, market risk, foreign exchange risk, and liquidity risk.

 

OUTSTANDING SHARE DATA

 

As of April 30, 2024, the following securities were outstanding:

 

Common stock: 419,553,485 shares

Series A Preferred Stock: 10,000,000

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a Smaller Reporting Company, as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K, we are electing scaled disclosure reporting obligations and therefore are not required to provide the information requested by this Item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

 

As required by Rule 13a-15 of the Securities Exchange Act of 1934, our principal executive officer and principal financial officer evaluated our company's disclosure controls and procedures (as defined in Rules 13a-15(e) of the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of the end of the period covered by this report, these disclosure controls and procedures were not effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities Exchange Commission and to ensure that such information is accumulated and communicated to our company's management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure. The conclusion that our disclosure controls and procedures were not effective was due to the presence of the following material weaknesses in internal control over financial reporting which are indicative of many small companies with small staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

 

We plan to take steps to enhance and improve the design of our internal controls over financial reporting. During the period covered by this quarterly report on Form 10-Q, we have not been able to remediate the material weaknesses identified above. To remediate such weaknesses, we plan to implement the following changes during our fiscal year ending October 31, 2024, subject to obtaining additional financing: (i) appoint additional qualified personnel to address inadequate segregation of duties and ineffective risk management; and (ii) adopt sufficient written policies and procedures for accounting and financial reporting. The remediation efforts set out above are largely dependent upon our securing additional financing to cover the costs of implementing the changes required. If we are unsuccessful in securing such funds, remediation efforts may be adversely affected in a material manner.

 

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake.

 

 23 
 

CHANGES IN INTERNAL CONTROLS OVER FINANCIAL REPORTING

 

There were no changes in our internal control over financial reporting during the quarter ended April 30, 2024 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

ITEM 1A. RISK FACTORS

 

The following risk factor disclosures should be read in conjunction with the risk factors described in our Annual Report on Form 10-K for the year ended October 31, 2023 and subsequent periodic filings with the SEC. We are supplementing the risk factors previously disclosed in such filings to include the following updated risk factors:

 

Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this Quarterly Report, including our financial statements and the related notes thereto and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as any additional risk factors that may be described in our other filings with the SEC from time to time, including our Annual Report on Form 10-K for fiscal year ended October 31, 2023, before deciding whether to invest in our securities. The occurrence of any of the risks, the events or developments described below could harm our business, financial condition, operating results, and growth prospects. In such an event, the market price of our common stock could decline, and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. You should consider carefully the risks and uncertainties summarized and set forth in detail below and elsewhere in this Annual Report before you decide to invest in our common stock.

 

You are unlikely to be able to exercise effective remedies or collect judgments against BF Borgers relating to their work as our independent registered public accounting firm.

BF Borgers CPA PC (“BF Borgers”) served as our independent registered public accounting firm from 2022 to 2024 and audited the consolidated financial statements contained in our Annual Report on Form 10-K for the years ended October 30, 2023 and 2022. On May 3, 2024, the SEC entered an order instituting settled administrative and cease-and-desist proceedings against BF Borgers, permanently barring BF Borgers from appearing or practicing before the Commission as an accountant (the “Order”). In light of the Order, we dismissed BF Borgers as our independent registered public accounting firm on May 6, 2024. We have no ability to ascertain whether BF Borgers will survive or that adequate assets will be available to satisfy any claims against it. As a result, you may not be able to exercise effective remedies or collection judgements against BF Borgers. You may also be unable to seek remedies against BF Borgers under applicable securities laws for any untrue statement of a material fact contained in our past financial statements audited by BF Borgers or any omission of a material fact required to be stated in those financial statements. Also, it is unknown if any assets would be available from BF Borgers to satisfy any claims.

We may incur material expenses or delays in financings or SEC filings due to the dismissal of BF Borgers and our stock price and access to the capital markets may be affected.

As a public company, we are required to file with the SEC financial statements that are audited or reviewed, as applicable, by an independent registered public accountant. Our access to the capital markets and our ability to make timely filings with the SEC will depend on having financial statements audited or reviewed again by a new independent registered public accounting firm. In addition, because the SEC found that BF Borgers deliberately failed to conduct audits and quarterly reviews in accordance with applicable PCAOB standards and fraudulently issued audit reports, we will not be able to rely on BF Borgers to provide other information or documents that would customarily be received by us or underwriters in connection with financings or other transactions, including consents and “comfort” letters. As a result, we may encounter delays, additional expense and other difficulties in future financings. Any resulting delay in accessing or inability to access the public capital markets could be disruptive to our operations and could affect the price and liquidity of our securities. Any negative news about the proceedings against BF Borgers may also adversely affect investor confidence in companies that were previous clients of BF Borgers. All of these factors could materially and adversely affect the market price of our common stock and our ability to access the capital markets.

 

 24 
 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

The following table includes all unregistered sales of securities made by the Company during the quarter ended April 30, 2024:

  

Date Name Consideration Securities Exemption from Registration
2/1/2024 Raymond Williams Jr Cash             3,000 Regulation A
2/15/2024 Michael Ledgister Cash             1,000 Regulation A
2/15/2024 Sundaramoorthy Kanagarajan Cash             2,000 Regulation A
2/16/2024 Ariel Benkadmiel McCullough Cash             1,000 Regulation A
2/17/2024 Nathaniel Harris Cash             1,000 Regulation A
2/22/2024 Venetria Nicole Davis Cash             1,000 Regulation A
2/22/2024 Ariel Benkadmiel McCullough Cash             1,000 Regulation A
2/25/2024 Cory Renaldo Brown Cash             1,000 Regulation A
2/26/2024 Edward L Cryer & Shirley Neal, JTWROS Cash             1,000 Regulation A
2/29/2024 Annie Priester Cash             1,000 Regulation A
3/8/2024 Pamela Jean Harlan Cash             2,000 Regulation A
3/12/2024 Patrick Earl Nixon & Janice Lynn Nixon, JTWROS Cash             1,000 Regulation A
4/1/2024 Raymond Williams Jr Cash             2,000 Regulation A
4/5/2024 Ani N Rooney Cash           10,000 Regulation A
4/5/2024 Farah Chikita Stephens-Travis Cash             1,000 Regulation A
4/5/2024 Donte Small Cash             2,000 Regulation A
4/6/2024 Jacqueline D Brooks Cash             1,500 Regulation A
4/6/2024 Paul James Chatman Cash             1,200 Regulation A
4/6/2024 Roland Cyprian Roberts Cash             5,000 Regulation A
4/6/2024 Johnnie Edward Rozier Jr & Jacqueline Bazile Rozier, JTWROS Cash             3,000 Regulation A
4/6/2024 Rachael Moore Cash             1,000 Regulation A
4/7/2024 Samuel Austin Cutler Cash             7,500 Regulation A
4/7/2024 Scy Vincent Banks Cash             1,000 Regulation A
4/8/2024 Antoinette Almeda Benton Cash             1,000 Regulation A
4/9/2024 Jacklyn L Hagood Cash             1,000 Regulation A
4/9/2024 Sabrina Jackson Cash             1,000 Regulation A
4/9/2024 Michelle Marie Cabrera Cash             2,500 Regulation A
4/11/2024 Willie Cal Brown Cash             1,000 Regulation A
4/11/2024 LaVetta Dodd-Ivy Cash             1,000 Regulation A
4/11/2024 Phillip McNeal & Janeen McNeal, JTWROS Cash             1,200 Regulation A
4/13/2024 Tangula Renee Hudson Cash             1,000 Regulation A
4/15/2024 Edward Joe Bentley III Cash             3,000 Regulation A
4/15/2024 Nathaniel Harris Cash             1,000 Regulation A
4/16/2024 Raymond Williams Jr. Cash             7,000 Regulation A
4/17/2024 Kevin Bens Cash             1,000 Regulation A
4/17/2024 Delhia M. Emanuel - Emanuel Soler Trust Cash             2,000 Regulation A
4/17/2024 Neishana Morrison Cash             1,000 Regulation A
4/17/2024 Roxanne Lolita Patterson Cash             1,000 Regulation A
4/17/2024 Wesley Bryant Cash             1,000 Regulation A
4/17/2024 Sarita R Allen Cash             1,000 Regulation A
4/18/2024 Patrick Earl Nixon & Janice Lynn Nixon, JTWROS Cash             2,000 Regulation A
4/18/2024 Cynthia Dianne Walls Cash             1,000 Regulation A
4/21/2024 Wesley Clifford Allen Cash             5,000 Regulation A
4/22/2024 Kevin Bens Cash             1,000 Regulation A
4/22/2024 Vivian D Carlo & Delhia M. Emanuel, JTWROS Cash             2,000 Regulation A
4/22/2024 Marion D Fulce & Dwight D Fulce, JTWROS Cash             1,500 Regulation A
4/23/2024 Hortensia M. Emanuel Revocable Living Trust Cash             1,000 Regulation A
4/24/2024 Alice Jones Cash             1,000 Regulation A
4/25/2024 Omega Ashanti Dennis Cash             1,000 Regulation A
 25 
 

4/25/2024 Sammie Lucille Love Cash             1,250 Regulation A
4/25/2024 Rickey Anthony Lumpkin & Bertha Lois Lumpkin, JTWROS Cash             5,000 Regulation A
4/25/2024 Clarence R Simmons Cash             2,000 Regulation A
4/26/2024 Sabrina Jackson Cash             1,000 Regulation A
4/26/2024 Dixie Robinson Miss Cash             1,000 Regulation A
4/26/2024 Laura Weida Cash             1,000 Regulation A
4/27/2024 Dyland S Haile Cash             1,000 Regulation A
4/27/2024 Antonio L. Jones Cash             2,000 Regulation A
4/28/2024 Justin Albert Brannon Cash             2,500 Regulation A
4/28/2024 Sonia Hansen Cash             2,000 Regulation A
4/28/2024 Sara Hare Cash             3,000 Regulation A
4/28/2024 Lorna Karen Haynes Cash             1,000 Regulation A
4/28/2024 Michael Sanford King Cash             2,500 Regulation A
4/28/2024 Edward G. McCurbin Cash             2,000 Regulation A
4/28/2024 Christopher Norwood Cash             1,000 Regulation A
4/28/2024 Darryl Christopher Wood Cash             1,000 Regulation A
4/29/2024 Ezekiel Carter & Ruby J Carter, JTWROS Cash             1,000 Regulation A
4/29/2024 Theresa Johnson Cash             1,000 Regulation A
4/29/2024 Niecole D Kelly Cash             1,000 Regulation A
4/29/2024 Steven L Martin Cash             2,500 Regulation A
4/29/2024 John Moncure Cash             1,000 Regulation A
4/29/2024 Randolph David Plunkett Cash             1,000 Regulation A
4/29/2024 Joanne Simone Rollocks Cash             1,500 Regulation A
4/29/2024 Antonio Renard Woodfin Cash           10,000 Regulation A
4/30/2024 Jefferson Davis Lewis III Cash             1,000 Regulation A
4/30/2024 Ani N Rooney Cash           40,000 Regulation A
4/30/2024 Tonjia Lynn Stone Cash             1,000 Regulation A

 

ITEM 5. OTHER INFORMATION

Securities Trading Plans of Directors and Executive Officers

None of our directors or executive officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (as such terms are defined in Item 408(c) of Regulation S-K) during the three months ended April 30, 2024.

 

 

 

 26 
 

ITEM 6. EXHIBITS

 

      Incorporated by reference
Exhibit Exhibit Description Filed herewith Form Period ending Exhibit Filing date
31.1 Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X        
31.2 Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 X        
32.1* Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X        
32.2* Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 X        
101.INS Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document XBRL Instance Document X        
101.SCH Inline XBRL Taxonomy Extension Schema Document X        
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X        
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X        
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X        
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Definition X        
104 Cover page formatted as Inline XBRL and contained in Exhibit 101          

 

* Furnished, not filed.

 27 
 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   
 

HNO INTERNATIONAL INC.

 

   
   
June 27, 2024

By: /s/ Paul Mueller

Paul Mueller, Chief Executive Officer

(Principal Executive Officer)

   
June 27, 2024

By: /s/ Hossein Haririnia

Hossein Haririnia, Treasurer

(Principal Financial and Accounting Officer)

 

 

 

 

 

 

 

 

 

 28